摘要
原发性肝癌(primary hepatic carcinoma,PHC)的病因病机为本虚标实,扶正补虚类中药治疗原发性肝癌的研究近年来取得了一定进展,其在改善患者的生存质量、延长生存期等方面的优势已引起临床专家的重视,文中将近5年来扶正补虚中药防治肝癌的研究进展作一综述,为进一步提高中医药防治肿瘤的疗效提供参考。
The etiology and pathogenesis of primary hepatic carcinoma （PHC） are characterized by Ben deficiency and Biao excess. Evil-expelling Chinese drugs have been applied to the treatment of PHC in recent years, and exhibited their efficacy in improv ing the quality of life and prolonging the survival of the patients. This article presents an overview of the studies in the recent 5 years on the evil-expelling Chinese drugs for the prevention and treatment of the PHC.
出处
《医学研究生学报》
CAS
北大核心
2012年第12期1341-1344,共4页
Journal of Medical Postgraduates
关键词
原发性肝癌
中药
扶正补虚
Primary hepatic carcinoma
Chinese medicine
Evil-expelling
